Effectiveness of radiation therapy for older women with early breast cancer Journal Article


Authors: Smith, B. D.; Gross, C. P.; Smith, G. L.; Galusha, D. H.; Bekelman, J. E.; Haffty, B. G.
Article Title: Effectiveness of radiation therapy for older women with early breast cancer
Abstract: Background: Recent clinical trials have questioned the necessity of breast radiation therapy for older women with early breast cancer. However, the effectiveness of radiation therapy for older women in the community setting has not been addressed. Methods: We used the Surveillance, Epidemiology, and End Results (SEER)-Medicare database from January 1, 1992, through December 31, 1999, to identify 8724 women aged 70 years or older treated with conservative surgery for small, lymph node-negative, estrogen receptor-positive (or unknown receptor status) breast cancer. We used a proportional hazards model to test whether radiation therapy was associated with a lower risk of a combined outcome, defined as a second ipsilateral breast cancer reported by SEER and/or a subsequent mastectomy reported by Medicare claims. All statistical tests were two-sided. Results: Radiation therapy, compared with no radiation therapy, was associated with a lower risk of the combined outcome (hazard ratio = 0.19, 95% confidence interval = 0.14 to 0.28). Radiation therapy was associated with an absolute risk reduction of 4.0 events per 100 women at 5 years (i.e., from 5.1 events without radiation therapy to 1.1 with radiation therapy) and 5.7 events per 100 persons at 8 years (i.e., from 8.0 events without radiation therapy to 2.3 with radiation therapy) (P <.001, log-rank test). Radiation therapy was most likely to benefit those aged 70-79 years without comorbidity (number needed to treat [NNT] to prevent one event = 21 to 22 patients) and was least likely to benefit those aged 80 years or older with moderate to severe comorbidity (NNT = 61 to 125 patients). Conclusion: For older women with early breast cancer, radiation therapy was associated with a lower risk of a second ipsilateral breast cancer and subsequent mastectomy. Patients aged 70-79 years with minimal comorbidity were the most likely to benefit, and older patients with substantial comorbidity were least likely to benefit. © Copyright 2006 Oxford University Press.
Keywords: controlled study; treatment outcome; aged; aged, 80 and over; retrospective studies; major clinical study; clinical trial; cancer recurrence; united states; adjuvant therapy; cancer adjuvant therapy; cancer radiotherapy; comparative study; radiotherapy, adjuvant; recurrence risk; antineoplastic agent; metabolism; neoplasm recurrence, local; breast cancer; mastectomy; proportional hazards models; odds ratio; risk factors; age factors; pathology; breast neoplasms; retrospective study; risk factor; age; risk assessment; risk; confidence interval; medicare; proportional hazards model; statistical significance; early cancer; tumor recurrence; breast tumor; comorbidity; cancer registry; seer program; estrogen receptor; risk reduction; elderly care; clinical trials; segmental mastectomy; mastectomy, segmental; log rank test
Journal Title: JNCI: Journal of the National Cancer Institute
Volume: 98
Issue: 10
ISSN: 0027-8874
Publisher: Oxford University Press  
Date Published: 2006-05-17
Start Page: 681
End Page: 690
Language: English
DOI: 10.1093/jnci/djj186
PUBMED: 16705122
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 59" - "Export Date: 4 June 2012" - "CODEN: JNCIA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors